Spinal muscular atrophy patients have urged the Hong Kong government to expand subsidised medicine options for adults to increase their chances for a better quality of life, with some saying their condition deteriorated after growing up without affordable care. Lui Man-lam, president of the Hong Kong Neuro-Muscular Disease Association, said at a press conference on Sunday that while oral medicine

Hong Kong’s spinal muscular atrophy patients seek aid for injection therapy
Jess Ma·South China Morning Post··1 min readLimited
S
Continue reading on South China Morning Post
This article was sourced from South China Morning Post's RSS feed. Visit the original for the complete story.
Limited free access — this source offers metered access before requiring a subscription.